😎 Sommerzeit, Hammer-Deals! Bei InvestingPro winken jetzt bis zu 50% Rabatt auf KI-Aktien-TippsJETZT ZUGREIFEN

DGAP-News: Ebix Enters Medical E-Learning & M-Learning Markets by Acquiring Montreal Based Taimma Communications Inc. (deutsch)

Veröffentlicht am 02.04.2012, 13:00
Aktualisiert 02.04.2012, 13:04
Ebix Enters Medical E-Learning & M-Learning Markets by Acquiring Montreal Based Taimma Communications Inc.

Ebix, Inc.

02.04.2012 13:00

---------------------------------------------------------------------------

-- Taimma to be merged into Ebix's A.D.A.M. Division

-- Expands Ebix's Reach into the Biotechnology and Pharmaceutical Industries

-- Ebix to use Taimma's Mobile expertise to sell Medical Apps on Apple's

iTunes Store

ATLANTA, 2012-04-02 13:00 CEST (GLOBE NEWSWIRE) -- Ebix, Inc. (Nasdaq:EBIX), a

leading international supplier of On-Demand software and E-commerce services to

the insurance industry, today announced that it has signed an agreement to

acquire Montreal based Taimma Communications Inc., a leading provider of

innovative E-Learning medical education solutions to the pharmaceutical,

biotechnology and healthcare industries. Ebix also announced that Taimma would

be immediately integrated into its A.D.A.M. Health Information Exchange

Division.

Ebix expects the transaction to be accretive to Ebix Earnings per Share (EPS).

Ebix disclosed that it funded this transaction completely in cash using its

existing cash reserves. No Ebix shares were issued and no investment bankers

were involved in the transaction on the Ebix side.

Founded in 2005, Taimma specializes in providing innovative, best-in-class,

custom, and off-the-shelf medical learning programs to meet the unique needs of

the biomedical and pharmaceutical industries. Taimma's state-of-the-art

E-Learning platform provides a variety of services to be utilized by the

principal constituents involved in the Health insurance industry:

-- In addition to customized training, Taimma owns a library of over 140

courses and thousands of life science art elements developed by experienced

medical writers and artists.

-- Taimma brings to Ebix the technical expertise to develop customized mobile

learning ('M-Learning') materials that is presently available through

iTunes, Android and Amazon app stores. It also creates content that is

delivered through a variety of Learning Management Systems.

-- Taimma's R&D efforts have resulted in solving the problems related to

running Flash media on Apple devices. iTunes recently approved Taimma's

launch of Flash training content that runs on iPad, iPad2, and the iPhone.

-- Taimma's customer base includes many leading Pharmaceutical companies such

as Pfizer, Bayer, GlaxoSmithKline and Purdue etc. to whom the Company

provides customized medical M-Learning tools for training their sales

representatives.

-- For the healthcare industry, Taimma offers an intelligent engine for

converting traditional paper-based content into highly interactive

E-Learning modules. Additionally, its simulation- based training offers an

enriching experience that exposes users to real life clinical situations.

-- Taimma's products allow insurance companies and agencies to provide

comprehensive patient education programs. For example, Patient discharge

courses can be implemented to educate patients on their unique situation

and how to care for themselves post any operation. The area of patient

education is a big priority today for large insurance companies, state and

federal governments.

-- Taimma's ability to convert legacy content into engaging electronic media

can be leveraged to create extremely engaging M-learning content, while

replacing print media in the medical and healthcare communications

industry.

Ebix Chairman of the Board, President & CEO Robin Raina said, 'We are excited

to be entering the M-Learning markets through the acquisition of Taimma. The

success of the iPad and similar handheld devices has opened up tremendous

opportunities in the field of medical education and M-Learning. We intend to

utilize Taimma's technology and course expertise in this area to expand our

A.D.A.M. Division's reach further into newer areas like the Pharmaceutical &

Bio-Technology industries.'

'The combination of A.D.A.M. content and Taimma's M-Learning expertise & deep

pockets in the Pharmaceutical & Bio-Technology industries helps us to expand

the reach & depth of our Health Content Exchange.' Robin said, 'We are excited

with our ability to take our vast medical content and sell it in the form of

mobile Apps over worldwide distribution platforms like the Amazon and Apple's

iTunes stores.'

Taimma President Soula Chronopoulos said, 'Ebix is a logical home for Taimma,

as we were looking to be part of an innovative leading Company that could

expand our reach and vision of M-Learning across the world. The A.D.A.M.

expertise, health content and customer base is a perfect complement for

Taimma's courseware, E-learning content and technology. We are excited about

the possibilities this merger offers for both our customers and employees.'

About Taimma Communications Inc.

Taimma Communications Inc., is a leading provider of innovative E-Learning

medical education solutions to various constituents of the healthcare industry.

The Company specializes in the development of innovative, best-in-class,

custom, and off-the-shelf medical learning programs to meet the unique needs of

the biomedical and pharmaceutical industries. For more information, visit

http://www.taimma.com/

About Ebix, Inc.

A leading international supplier of On-Demand software and E-commerce services

to the insurance industry, Ebix, Inc., (Nasdaq:EBIX) provides end-to-end

solutions ranging from infrastructure exchanges, carrier systems, agency

systems and BPO services to custom software development for all entities

involved in the insurance industry.

With 30+ offices across Brazil, Singapore, Australia, the US, New Zealand,

India and Canada, Ebix powers multiple exchanges across the world in the field

of life, annuity, health and property & casualty insurance while conducting in

excess of $100 billion in insurance premiums on its platforms. Through its

various SaaS-based software platforms, Ebix employs hundreds of insurance and

technology professionals to provide products, support and consultancy to

thousands of customers on six continents. Ebix's focus on quality has enabled

it to be awarded Level 5 status of the Carnegie Mellon Software Engineering

Institute's Capability Maturity Model (CMM). With a recent ISO 27001-security

certification, the Company also has a ISO 9001:2000 certification for both its

development and BPO units in India. For more information, visit the Company's

website at www.ebix.com

The Ebix, Inc. logo is available at

http://www.globenewswire.com/newsroom/prs/?pkgid=12133

Steven Barlow

678-281-2043 or steve.barlow@ebix.com



or



Aaron Tikkoo

678-281-2027 or atikkoo@ebix.com

News Source: NASDAQ OMX

02.04.2012 Dissemination of a Corporate News, transmitted by DGAP -

a company of EquityStory AG.

The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------



Language: English

Company: Ebix, Inc.





United States

Phone:

Fax:

E-mail:

Internet:

ISIN: US2787152063

WKN:



End of Announcement DGAP News-Service



---------------------------------------------------------------------------

Aktuelle Kommentare

Installieren Sie unsere App
Risikohinweis: Beim Handel mit Finanzinstrumenten und/oder Kryptowährungen bestehen erhebliche Risiken, die zum vollständigen oder teilweisen Verlust Ihres investierten Kapitals führen können. Die Kurse von Kryptowährungen unterliegen extremen Schwankungen und können durch externe Einflüsse wie finanzielle, regulatorische oder politische Ereignisse beeinflusst werden. Durch den Einsatz von Margin-Trading wird das finanzielle Risiko erhöht.
Vor Beginn des Handels mit Finanzinstrumenten und/oder Kryptowährungen ist es wichtig, die damit verbundenen Risiken vollständig zu verstehen. Es wird empfohlen, sich gegebenenfalls von einer unabhängigen und sachkundigen Person oder Institution beraten zu lassen.
Fusion Media weist darauf hin, dass die auf dieser Website bereitgestellten Kurse und Daten möglicherweise nicht in Echtzeit oder vollständig genau sind. Diese Informationen werden nicht unbedingt von Börsen, sondern von Market Makern zur Verfügung gestellt, was bedeutet, dass sie indikativ und nicht für Handelszwecke geeignet sein können. Fusion Media und andere Datenanbieter übernehmen daher keine Verantwortung für Handelsverluste, die durch die Verwendung dieser Daten entstehen können.
Die Nutzung, Speicherung, Vervielfältigung, Anzeige, Änderung, Übertragung oder Verbreitung der auf dieser Website enthaltenen Daten ohne vorherige schriftliche Zustimmung von Fusion Media und/oder des Datenproviders ist untersagt. Alle Rechte am geistigen Eigentum liegen bei den Anbietern und/oder der Börse, die die Daten auf dieser Website bereitstellen.
Fusion Media kann von Werbetreibenden auf der Website aufgrund Ihrer Interaktion mit Anzeigen oder Werbetreibenden vergütet werden.
Im Falle von Auslegungsunterschieden zwischen der englischen und der deutschen Version dieser Vereinbarung ist die englische Version maßgeblich.
© 2007-2024 - Fusion Media Limited. Alle Rechte vorbehalten.